New page exploration in action with #Tigermed Tigermed fully integrated imaging evaluation services can provide comprehensive advice from early-stage development to Phase IV endpoints to improve critical decision-making considerations. Working with Tigermed’s #medical #imaging team benefits you with leading industrial experts' analysis and regulatory insight that will add value to your clinical development and management. We focus on providing medical imaging #CRO services and take the tenet of ‘Specialty, Dedication, Integrity’ to offer the best quality services for sponsors with high-speed feedback, reasonable prices and high-efficiency #execution. Learn more about Tigermed's capabilities and connect for a conversation at https://lnkd.in/gMHqgHqS
关于我们
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibilities for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.
- 网站
-
http://www.tigermedgrp.com
Tigermed的外部链接
- 所属行业
- 制药业
- 规模
- 5,001-10,000 人
- 总部
- Hangzhou,Zhejiang
- 类型
- 上市公司
- 创立
- 2004
- 领域
- BE study Generic Drugs Quality Consistency Evaluation、Preclinical/CMC/Bioanalytical、Clinical related services、Regulatory Affairs、Clinical trial---Phase I to IV & NIS和MART&Oversea clinical service
地点
-
主要
No.19 Jugong Road, Binjiang District
F18, Building A – Shengda Science Park
CN,Zhejiang,Hangzhou,310053
-
Changning District, Shanghai,P.R.China
Fl.16,999 West Zhongshan Road,
CN,Shanghai,Shanghai,200051
-
No.20 Chaoyangmen Outer Street,Chaoyang District, Beijing,P.R.China
Room 808,Union Mansion
CN,Beijing,Beijing,100020
Tigermed员工
动态
-
Dive into the heart of #Tigermed's #brand #culture with our employees' stories. In this edition, we explore the brand pillar of #Quality, reaffirming our commitment to innovative service and global health. We are pleased to invite Xixi Cheng to share her experience on Quality First is not only a slogan but also a working method and code of conduct. "I believe that ‘Quality’ is one of the most important principles in clinical trials. We always prioritize quality and ensure that our projects are completed to high standards through various methods such as regular SOP training and sharing CAPA cases. There is a case in the industry where a clinical trial was halted due to the sponsor's excessive focus on enrollment speed, leading to significant protocol deviations. This incident left a deep impression on me, reminding us that while we might ensure enrollment efficiency, we must not overlook the quality of the trial. Any compromise on quality may have adverse effects on the eventual market approval of the product. This case also made me realize deeply that Tigermed's commitment to ‘Quality’ lies in the rigor and professionalism throughout the process. We also adhere to this guiding principle to provide our clients with higher quality services."
-
New page exploration in action with #Tigermed #Vaccine research is unique in its ability to have a widespread impact on global health. Now more than ever, vaccine development requires a more innovative and efficient approach. Our vaccine service scope covers vaccine clinical #design, #monitoring, data #statistics and biological #testing, we work closely with you to develop personalized roadmaps for your vaccine study and aim to maximize efficiency, anticipate challenges, and mitigate risk. Learn more about Tigermed's capabilities and connect for a conversation at https://lnkd.in/gm_Wkqir
-
What an incredible week at #DIA 2024! From June 16th to 20th, Tigermed was immersed in an environment brimming with #innovation, #collaboration, and #forward-thinking discussions, presenting our pioneering solutions and demonstrating our unwavering commitment to excellence in clinical trials. A heartfelt thank you to everyone who visited our booth. Stay connected with Tigermed for more exciting updates and developments as we continue to shape the future of #healthcare together!
-
Dive into the heart of #Tigermed's #brand #culture with our employees' stories. In this edition, we explore the brand pillar of #Quality, reaffirming our commitment to innovative service and global health. We are pleased to invite Katie Ponce to share her experience on Quality First is not only a slogan but also a working method and code of conduct. "I joined the Tigermed in early March and attended the team's first meeting. Colleagues emphasized the importance of choosing appropriate methods in our work and shared the viewpoint that 'even if the statistical methods we choose cannot prove the success of the research product, these methods must be of high quality.' Therefore, I believe that ‘Quality’ not only means the success of the trial, but also ensures the reliability, rigor, and interpretability of the methods and results. Only high-quality work can produce high-quality results, and I am delighted to be part of the biostatistics team. Here, I see the team improving the quality of statistical work through various means, which fills me with confidence in focusing on research work related to oncology compounds and contributing to the biostatistics work in clinical trials."
-
We are thrilled to be heading back to the beautiful city of San Diego for #DIA2024! Each year DIA brings together professionals across all sectors of the life science community, with a common goal and passion for improving health outcomes for patients across the globe. We are excited to have the opportunity to reconnect with friends, colleagues and partners as well as to showcase what Tigermed is doing to enhance health and drive medical innovation for all! Whether you’re heading to DIA as well or just in the San Diego area, let us know or connect with Cooper Anderson at Tigermed’s booth #2021.
-
As the largest and most comprehensive biotech event, #BIO #International #Convention brings together over 18,500 industry leaders. Join Tigermed at the SWISS BIOTECH Pavilion, Booth #2111, from June 3-6. We're here to connect with industry leaders, innovators, and professionals from all over the world, and excited to explore potential collaborations and discover how we can work together to advance the future of #biotechnology.
-
What a fantastic day for team Tigermed at ASCO Annual Meeting 2024! It's been great to meet our partners and customers and have in-depth discussion on delivering clinical solutions for oncology breakthroughs. #asco #tigermed #clinicaltrials #clinicalresearch
-
Dive into the heart of #Tigermed's #brand #culture with our employees' stories. In this edition, we explore the brand pillar of #Human #Life, reaffirming our commitment to innovative service and global health. We are pleased to invite Julian Nathanael to share his experience on how to shape his #career and personal #growth in the Clinical Operations department and explore the meaning of "Human Life" together. “‘Human-Life’ has become an important principle in our work, which not only means that we value communication with every teammate around us, but also represents that we learn from each other and improve through one exchange to provide high-quality services for the benefit of more patients. Working in clinical research presents various challenges, such as data inconsistencies, protocol deviations, and participant recruitment difficulties. However, ‘Human-Life’ is our key to overcoming these challenges. For example, when we encountered a significant amount of unencoded data, we collaborated with the project team, investigators, and site staff to discuss potential causes and solutions. We utilize all available resources, both from the site staff and CRAs, for the swift completion of data entry and verification. This is because Tigermed prides itself in placing people first, ensuring the accuracy of our data, and providing high-quality clinical trial services to benefit patients, as we remain steadfast in our commitment to give primacy to 'Human-Life’ above all else.”
-
Join Alice Lin, Director of DCT Solutions at Tigermed, as she discusses the transformative impact of technology in decentralized clinical trials. Alice shares insights on enhancing patient recruitment and retention, and how Tigermed’s patient-centric approach is paving the way for a more accessible and flexible clinical trial experience. Learn about innovative digital solutions and technologies that are reshaping the clinical trial landscape, and Tigermed’s pioneering role in driving this evolution. Don't miss this engaging discussion! #DCT #DecentralizedClinicalTrials #MedTech #RemoteMonitoring https://lnkd.in/gZREFT4J